Sandra Gurrola

Sr. Vice President of Finance at Ernexa Therapeutics.

Raised on Ernexa Therapeutics filings

$7.2M

of $7.2M offered across 1 Form D filing

Company

Biotech · Cambridge, MA

Off-the-shelf stem cell therapy for ovarian cancer

Off-the-shelf stem cell therapy for ovarian cancer

Ernexa Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Apr 11, 2025	Equity	$7.2M/ $7.2M	Form D

Also named on Ernexa Therapeutics filings